Finally, we performed differential expression analysis between top and bottom-quartile NCBP2-expressing TCGA OSCC patients to identify potential tumour-promoting factors that are upregulated downstream of NCBP2. Our studies have established NCBP2 as a bona fide prognostic marker and potential therapeutic target in OSCC. Here, NCBP2 is linked to neoplasm.